Navigation Links
Liberty Institute: Government "Accommodation" Still Requires Employers To Facilitate Coverage Of Abortifacient Drugs
Date:8/22/2014

WASHINGTON, Aug. 22, 2014 /PRNewswire-USNewswire/ -- Today, the Obama Administration issued new regulations under Obamacare that modify the religious "accommodation" but still require religious organizations to facilitate insurance coverage for drugs that have an abortifacient effect, including Plan B (the "morning after pill") and Ella (the "week after pill"). The Obama Administration also announced that it is investigating expanding the "accommodation" to religious, closely held, for-profit corporations.

The regulations issued today keep the same "accommodation" in place but provide an alternative means of accepting the "accommodation." Instead of submitting the previously required form, religious organizations may now elect instead to notify the government in writing of their objection to providing the abortifacient coverage using words of the organization's own choice.

"Eliminating the requirement of using the government's form does not eliminate moral liability for facilitating coverage of these abortifacient drugs," said Jeff Mateer, general counsel of Liberty Institute. "These new regulations are a mere hand wave to Americans who, inspired by their deep religious commitment, oppose providing drugs that may kill an unborn baby."

Last month, in the wake of the Hobby Lobby and Wheaton College Supreme Court decisions prohibiting the Obama Administration from forcing religious employers to facilitate or provide coverage for these abortifacient drugs, the administration announced that it would issue new regulations that would protect religious employers' religious freedom. Those new regulations, issued today, keep the same fundamental system in place to which so many employers have objected.

Under the "religious accommodation," religious organizations could submit a form that would trigger a requirement that the organization's insurance provider cover the objectionable drugs. Many faith-based organizations objected that forcing their insurance providers to cover drugs like Plan B and Ella was no less morally objectionable than including the drugs directly in the organizations' health insurance policies.

Liberty Institute is a nonprofit legal group dedicated to defending and restoring religious liberty across America — in our schools, for our churches, in the military and throughout the public arena. Liberty's vision is to reestablish religious liberty in accordance with the principles of our nation's Founders. For information, visit www.LibertyInstitute.org.

Logo - http://photos.prnewswire.com/prnh/20120523/DC12743LOGO-b


'/>"/>
SOURCE Liberty Institute
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Liberty Design Secures GSA Award, to Supply Federal Agencies
2. New England Laser Options Adds On Professional Hair Removal with the Astanza Liberty IPL System
3. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
4. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
5. The American Council for Patient Liberty on medical marijuana vending machines
6. Liberty Dialysis Celebrates Milestone 1,000th Patient in Peritoneal Dialysis Program
7. Incentivated Helps Scottish Government Service Consumers by SMS
8. Government Affairs & Public Policy Groups Playing Critical Role in Patient Engagement, Reports Best Practices, LLC
9. State Governments May Spend $55 Billion on Hepatitis C Medications
10. Government Testing Error Forces Delay in Planned Launch of New MSA Air Masks
11. AMRI Awarded Development and Manufacture Contract from the UK Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... RK Logistics Group, Inc. was awarded California ... Fremont, CA headquarters facility where it provides full-spectrum ... San Jose for hi-tech, pharmaceutical and biomedical devices ... its Fremont Innovation District, is excited to strategically partner with ... the hundreds of biotech, pharma and biomed companies throughout the ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
(Date:7/11/2017)... -- Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe and ... painful intercourse and other painful pelvic pain conditions such as pelvic floor ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s ...
Breaking Medicine Technology:
(Date:7/20/2017)... ROUGE, La. (PRWEB) , ... July 20, 2017 , ... ... to the staff. Dr. Dunbar received his BS in Biology from LSU, graduating summa ... the Medical School Class President. After his residency in St. Louis, Dr. Dunbar moved ...
(Date:7/20/2017)... ... , ... A budget proposal to switch to an alternate consumer price index, ... is a bad deal for older and disabled Americans, says The Senior Citizens ... more slowly than the conventional one that is currently used to determine the annual ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), ... based Health IT business unit of Constellation Inc., a move that will help the ... of operations in St. Louis, the acquisition is expected to help MTS ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... “Fidget”: a ... Sisk, a retired public high school music and drama teacher who was a summa ... educational career, including a “Teacher of the Year” award. After her retirement from public ...
(Date:7/18/2017)... , ... July 18, 2017 , ... The results of an international clinical trial, led ... therapy for a severe type of muscular dystrophy holds promise for a subgroup of patients. ... Craig McDonald and colleagues at 53 study sites in 18 countries describe the clinical ...
Breaking Medicine News(10 mins):